{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:55:02Z","timestamp":1760820902177},"reference-count":30,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1136\/thoraxjnl-2017-210067","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T00:55:22Z","timestamp":1493945722000},"page":"905-911","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease"],"prefix":"10.1136","volume":"72","author":[{"given":"Daniel","family":"Kotz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Viechtbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin R","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onno C P","family":"van Schayck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziz","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,5,4]]},"reference":[{"issue":"(4)","key":"key-10.1136\/thoraxjnl-2017-210067-1","first-page":"CD006103","article-title":"Nicotine receptor partial agonists for smoking cessation","author":"Cahill","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"(1)","key":"key-10.1136\/thoraxjnl-2017-210067-2","first-page":"CD000031","article-title":"Antidepressants for smoking cessation","author":"Hughes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"(8)","key":"key-10.1136\/thoraxjnl-2017-210067-3","first-page":"CD010744","article-title":"Smoking cessation for people with chronic obstructive pulmonary disease","author":"van Eerd","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.1136\/thoraxjnl-2017-210067-4","unstructured":"US Food and Drug Administration, FDA alert [July 1, 2009]: Information for Healthcare Professionals: Varenicline (marketed as Chantix) and Bupropion (marketed as Zyban, Wellbutrin and generics). http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm169986.htm (accessed 3 Jan 2017)."},{"key":"key-10.1136\/thoraxjnl-2017-210067-5","unstructured":"US Food and Drug Administration. Drug Safety Communication [December 16, 2016]: FDA revises description of mental health side effects of the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) to reflect clinical trial findings. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm532221.htm (accessed 3 Jan 2017)"},{"key":"key-10.1136\/thoraxjnl-2017-210067-6","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"key":"key-10.1136\/thoraxjnl-2017-210067-7","doi-asserted-by":"crossref","first-page":"e2856","DOI":"10.1136\/bmj.e2856","article-title":"Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis","volume":"344","author":"Prochaska","year":"2012","journal-title":"BMJ"},{"key":"key-10.1136\/thoraxjnl-2017-210067-8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jama.2013.283787","article-title":"Pharmacological treatments for smoking cessation","volume":"311","author":"Cahill","year":"2014","journal-title":"JAMA"},{"key":"key-10.1136\/thoraxjnl-2017-210067-9","doi-asserted-by":"crossref","first-page":"pii: e002849","DOI":"10.1161\/JAHA.115.002849","article-title":"Varenicline and adverse cardiovascular events: a systematic review and meta-analysis of randomized controlled trials","volume":"5","author":"Sterling","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"key-10.1136\/thoraxjnl-2017-210067-10","doi-asserted-by":"crossref","first-page":"e7176","DOI":"10.1136\/bmj.e7176","article-title":"Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study","volume":"345","author":"Svanstr\u00f6m","year":"2012","journal-title":"BMJ"},{"key":"key-10.1136\/thoraxjnl-2017-210067-11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S2213-2600(15)00320-3","article-title":"Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study","volume":"3","author":"Kotz","year":"2015","journal-title":"Lancet Respir Med"},{"key":"key-10.1136\/thoraxjnl-2017-210067-12","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic pulmonary disease (2017 report). Global Initiative for Chronic Obstructive Lung Disease, Inc, 2017. http:\/\/goldcopd.org (accessed 4 Jan 2017)."},{"key":"key-10.1136\/thoraxjnl-2017-210067-13","volume-title":"Global strategy for the diagnosis, management and prevention of chronic pulmonary disease. Updated 2015","author":"Global Initiative for Chronic Obstructive Lung Disease","year":"2015"},{"key":"key-10.1136\/thoraxjnl-2017-210067-14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1183\/09031936.00092614","article-title":"Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit","volume":"46","author":"Jim\u00e9nez-Ruiz","year":"2015","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2017-210067-15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1183\/09031936.00060806","article-title":"Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy","volume":"29","author":"T\u00f8nnesen","year":"2007","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2017-210067-16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-14-1024","article-title":"Use of varenicline for smoking cessation treatment in UK primary care: an association rule mining analysis","volume":"14","author":"Huang","year":"2014","journal-title":"BMC Public Health"},{"key":"key-10.1136\/thoraxjnl-2017-210067-17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000341638","article-title":"Effectiveness of varenicline as an aid to smoking cessation in primary care: an observational study","volume":"19","author":"Andreas","year":"2013","journal-title":"Eur Addict Res"},{"key":"key-10.1136\/thoraxjnl-2017-210067-18","doi-asserted-by":"crossref","first-page":"e005281","DOI":"10.1136\/bmjopen-2014-005281","article-title":"Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database","volume":"4","author":"Kotz","year":"2014","journal-title":"BMJ Open"},{"key":"key-10.1136\/thoraxjnl-2017-210067-19","author":"US Food and Drug Administration, FDA Briefing Document"},{"key":"key-10.1136\/thoraxjnl-2017-210067-20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.54.7.581","article-title":"Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease","volume":"54","author":"Bestall","year":"1999","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2017-210067-21","doi-asserted-by":"crossref","first-page":"f5704","DOI":"10.1136\/bmj.f5704","article-title":"Smoking cessation treatment and risk of depression, suicide and self harm in the Clinical Practice Research Datalink: prospective cohort study","volume":"347","author":"Thomas","year":"2013","journal-title":"BMJ"},{"key":"key-10.1136\/thoraxjnl-2017-210067-22","doi-asserted-by":"crossref","first-page":"b3805","DOI":"10.1136\/bmj.b3805","article-title":"Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database","volume":"339","author":"Gunnell","year":"2009","journal-title":"BMJ"},{"key":"key-10.1136\/thoraxjnl-2017-210067-23","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1503\/cmaj.110218","article-title":"Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis","volume":"183","author":"Singh","year":"2011","journal-title":"Can Med Assoc J"},{"key":"key-10.1136\/thoraxjnl-2017-210067-24","author":"Townsend","year":"1988","journal-title":"Health and deprivation: inequality and the North"},{"key":"key-10.1136\/thoraxjnl-2017-210067-25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2296-11-1","article-title":"Adaptation and validation of the Charlson Index for Read\/OXMIS coded databases","volume":"11","author":"Khan","year":"2010","journal-title":"BMC Fam Pract"},{"key":"key-10.1136\/thoraxjnl-2017-210067-26","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2307\/2533848","article-title":"Assessing the sensitivity of regression results to unmeasured confounders in observational studies","volume":"54","author":"Lin","year":"1998","journal-title":"Biometrics"},{"key":"key-10.1136\/thoraxjnl-2017-210067-27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1378\/chest.10-0865","article-title":"effects of varenicline on smoking cessation in patients with mild to moderate COPD","volume":"139","author":"Tashkin","year":"2011","journal-title":"Chest"},{"key":"key-10.1136\/thoraxjnl-2017-210067-28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1360-0443.2012.04024.x","article-title":"Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System","volume":"108","author":"Meyer","year":"2013","journal-title":"Addiction"},{"key":"key-10.1136\/thoraxjnl-2017-210067-29","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/add.13329","article-title":"A comparison of neuropsychiatric adverse events during early treatment with varenicline or a nicotine patch","volume":"111","author":"Cunningham","year":"2016","journal-title":"Addiction"},{"key":"key-10.1136\/thoraxjnl-2017-210067-30","unstructured":"US Food and Drug Administration. Transcript for the 16 October 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM). http:\/\/www.fda.gov\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/PsychopharmacologicDrugsAdvisoryCommittee\/ucm394880.htm (accessed 9 Jul 2015)."}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2017-210067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T06:01:25Z","timestamp":1601100085000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2017-210067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,4]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,9,13]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1136\/thoraxjnl-2017-210067"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2017-210067","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,4]]}}}